As a five-time MMIT Patient Choice Award Winner with a portfolio of 25+ rare programs, PANTHERx attributes much of our success to our ability to hire and cultivate talent while simultaneously investing in state-of-the-art proprietary technology systems. With the expected surge of FDA rare medication approvals over the next decade, talent and technology will become increasingly crucial in order to continue to serve this growing patient population. To successfully complete, pharmacies will be required to adapt and scale their operations, expanding their knowledge and experience while keeping patient care front of mind.

Change has been a constant in the specialty pharmacy industry since its inception over two decades ago. New medications are routinely launched, more patient populations receive treatment, and public awareness of rare diseases has increased. Additionally, industry players and their specialty pharmacy management strategies have evolved to meet the needs of increasingly complicated treatments and the patients they serve.